Climb Bio Inc (NASDAQ: CLYM) established initial surge of 2.22% at $1.84, as the Stock market unbolted on Wednesday, before settling in for the price of $1.8 at the close. Taking a more long-term approach, CLYM posted a 52-week range of $1.05-$3.30.
The Healthcare sector firm’s twelve-monthly sales growth has been -40.44% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -40.44%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 47.13%. This publicly-traded company’s shares outstanding now amounts to $68.18 million, simultaneously with a float of $62.39 million. The organization now has a market capitalization sitting at $125.46 million. At the time of writing, stock’s 50-day Moving Average stood at $1.9706, while the 200-day Moving Average is $1.6032.
Climb Bio Inc (CLYM) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Climb Bio Inc industry. Climb Bio Inc’s current insider ownership accounts for 8.50%, in contrast to 65.50% institutional ownership. According to the most recent insider trade that took place on Jun 30 ’25, this organization’s President and CEO sold 20,618 shares at the rate of 1.22, making the entire transaction reach 25,154 in total value, affecting insider ownership by 48,132. Preceding that transaction, on Jun 20 ’25, Company’s SVP, Finance & CAO sold 1,242 for 1.24, making the whole transaction’s value amount to 1,540. This particular insider is now the holder of 18,888 in total.
Climb Bio Inc (CLYM) Earnings and Revenue Records
Climb Bio Inc’s EPS increase for this current 12-month fiscal period is 47.13% and is forecasted to reach -0.84 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 11.57% through the next 5 years, which can be compared against the -40.44% growth it accomplished over the previous five years trading on the market.
Climb Bio Inc (NASDAQ: CLYM) Trading Performance Indicators
Let’s observe the current performance indicators for Climb Bio Inc (CLYM). It’s Quick Ratio in the last reported quarter now stands at 18.38.
In the same vein, CLYM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.75, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.84 at the market close of one year from today.
Technical Analysis of Climb Bio Inc (CLYM)
Now, what If we examine the latest scores posted by [Climb Bio Inc, CLYM]. During the last 5-days, its volume was lower the volume of 0.43 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 42.86% While, its Average True Range was 48.44.
Raw Stochastic average of Climb Bio Inc (CLYM) in the period of the previous 100 days is set at 45.38%, which indicates a major fall in contrast to 55.56% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1196 that was lower than 0.1514 volatility it exhibited in the past 100-days period.
